SUSTAINED PD1 AND LAG3 EXPRESSION IN VIRAL RELATED HEPATOCELLULAR CARCINOMA POST STEREOTACTIC BODY RADIATION THERAPY (SBRT)

被引：0
|
作者：
Yadav, Pushpa [1 ]
Preedia, Babu E. [1 ]
Ramakrishna, Gayatri [1 ]
Yadav, Hanuman Prasad [2 ]
Sharma, Deepti [2 ]
Trehanpati, Nirupama [1 ]
机构：
[1] Inst Liver & Biliary Sci, Dept Mol & Cellular Med, New Delhi, India
[2] Inst Liver & Biliary Sci, Dept Radiat Oncol, New Delhi, India
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4532
引用
收藏
页码：S1404 / S1404
页数：1
相关论文
共 50 条
  • [41] Imaging post-stereotactic body radiation therapy responses for hepatocellular carcinoma: typical imaging patterns and pitfalls
    Katerina Mastrocostas
    Hyun-Jung Jang
    Sandra Fischer
    Laura A. Dawson
    Pablo Munoz-Schuffenegger
    Gonzalo Sapisochin
    Tae Kyoung Kim
    Abdominal Radiology, 2019, 44 : 1795 - 1807
  • [42] Orthotopic Liver Transplant (OLT) following Stereotactic Body Radiation Therapy (SBRT) in Patients with Hepatocellular Carcinoma (HCC): Radiologic and Pathologic Correlation
    Zook, J. E.
    Sandrasegaran, K.
    Saxena, R.
    Price, T.
    Maluccio, M.
    Kwo, P.
    Johnstone, P.
    Cardenes, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S285 - S286
  • [43] TIGIT expression in renal cell carcinoma infiltrating T cells is variable and inversely correlated with PD-1 and LAG3
    Perales, Oscar
    Jilaveanu, Lucia
    Adeniran, Adebowale
    Su, David G.
    Hurwitz, Michael
    Braun, David A.
    Kluger, Harriet M.
    Schoenfeld, David A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (10)
  • [44] Biologically effective dose (BED) of stereotactic body radiation therapy (SBRT) was an important factor of therapeutic efficacy in patients with hepatocellular carcinoma (≤5 cm)
    Jing Sun
    Tao Zhang
    Jia Wang
    Wengang Li
    Aimin Zhang
    Weiping He
    Dan Zhang
    Dong Li
    Junqiang Ding
    Xuezhang Duan
    BMC Cancer, 19
  • [45] Analysis of PD1, LAG3, TIGIT, and TIM3 expression in human lung adenocarcinoma reveals a 25-gene signature predicting immunotherapy response
    Guegan, Jean-Philippe
    Peyraud, Florent
    Dadone-Montaudie, Berengere
    Teyssonneau, Diego
    Palmieri, Lola-Jade
    Clot, Emma
    Cousin, Sophie
    Roubaud, Guilhem
    Cabart, Mathilde
    Leroy, Laura
    Lebreton, Coriolan
    Rey, Christophe
    Lara, Oren
    Odin, Ophelie
    Brunet, Maxime
    Vanhersecke, Lucile
    Gruyters, Ezogelin Oflazoglu
    Achour, Ikbel
    Belcaid, Leila
    Le Moulec, Sylvestre
    Grellety, Thomas
    Bessede, Alban
    Italiano, Antoine
    CELL REPORTS MEDICINE, 2024, 5 (12)
  • [46] Stereotactic Body Radiation Therapy (SBRT) Versus Transarterial Chemoembolization (TACE) for Treatment Of Hepatocellular Carcinoma: a Meta-Analysis of Propensity Matched Studies
    Jia, Sangyang
    Lao, Nicholas
    Boldt, R. Gabriel
    Mujoomdar, Amol
    Chow, Ronald
    Simone II, Charles B.
    Lock, Michael
    UNIVERSITY OF TORONTO MEDICAL JOURNAL, 2024, 101 (01) : 12 - 16
  • [47] Prognosis and Risk Factors of Recurrence in HBV-Related Small Hepatocellular Carcinoma After Stereotactic Body Radiation Therapy
    Han, Yifan
    Liu, Jianxiang
    Pan, Jiali
    Chen, Hongyu
    Tan, Ning
    Kang, Qian
    Yang, Yuqing
    Xu, Xiaoyuan
    Li, Wengang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Body mass index and serum alpha-fetoprotein level associated with PD1 expression and prognosis in patients with hepatocellular carcinoma
    Yang, Lili
    Wang, Jili
    Yao, Linpeng
    Chen, Cheng
    Pan, Junhan
    Peng, Ling
    Chen, Feng
    HELIYON, 2023, 9 (04)
  • [49] Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma (HCC): Rationale and Preliminary Data Supporting Hypothesis-driven Prospective Clinical Trial Development
    Fuss, M.
    Schwartz, J.
    Naugler, W.
    Urquhart, J.
    Orloff, S.
    Billingsley, K.
    Vaccaro, G.
    Koslin, B.
    Kolbeck, K.
    Kaufman, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S170 - S170
  • [50] A randomized phase II study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) as a bridge to transplant in hepatocellular carcinoma (HCC).
    Nugent, Francis Warren
    Gunturu, Krishna
    Stuart, Keith E.
    Flacke, Sebastian
    Molgaard, Chris
    Hunter, Klaudia
    Qamar, Amir
    Iqbal, Shams
    Gordon, Frederick
    Galuski, Kari
    Hartnett, Erin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345